mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.05 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
Vinblastine |
GDSC1000 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.05 |
mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.05 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.05 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
KIN001-270 |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.05 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.05 |